Markets:

Overview

News

Currencies

International

Treasuries

Lifecore Biomedical, Inc. - Common Stock (NQ:LFCR)

4.440 +0.090 (+2.07%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lifecore Biomedical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

NATIONALLY RANKED ROSEN LAW FIRM Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

April 23, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Regulatory Compliance

NATIONALLY RANKED ROSEN LAW FIRM Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

April 23, 2024

WHY: NEW YORK, NY - (NewMediaWire) - April 23, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Lifecore...

Via TheNewswire.com

Topics Regulatory Compliance

ROSEN, A RANKED AND LEADING FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

April 21, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Regulatory Compliance

ROSEN, A RANKED AND LEADING FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

April 21, 2024

WHY: NEW YORK, NY - (NewMediaWire) - April 21, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Lifecore...

Via TheNewswire.com

Topics Regulatory Compliance

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC

April 20, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report

April 19, 2024

From Lifecore Biomedical, Inc.

Via GlobeNewswire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC

April 15, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC

April 11, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress

April 01, 2024

From Lifecore Biomedical, Inc.

Via GlobeNewswire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors

March 28, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors

March 28, 2024

From Law Offices of Howard G. Smith

Via Business Wire

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

March 28, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors

March 26, 2024

From Law Offices of Frank R. Cruz

Via Business Wire

Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update

March 26, 2024

From Lifecore Biomedical, Inc.

Via GlobeNewswire

Lifecore Class Action Lawsuit Investigation News – Potential to Make Claim, Recover Losses, Contact Johnson Fistel, LLP

March 24, 2024

From Johnson Fistel, LLP

Via Business Wire

LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating Lifecore Biomedical, Inc. on Behalf of Lifecore Stockholders and Encourages Investors to Contact the Firm

March 22, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Lifecore Biomedical, Inc. (LFCR)

March 21, 2024

From Kirby McInerney LLP

Via Business Wire

Dow Surges 350 Points; Fed Holds Rates Steady ↗

March 20, 2024

U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also...

Via Benzinga

Topics Economy Stocks

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 20, 2024

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 20, 2024

Via Benzinga

Crude Oil Surges 2%; Signet Jewelers Shares Spike Higher ↗

March 20, 2024

U.S. stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve. The Dow traded up 0.03% to 39,123.89 while the NASDAQ fell 0.01% to 16,165.15. The S&P...

Via Benzinga

Topics Economy Stocks

US Stocks Edge Lower Ahead Of Fed's Decision; General Mills Earnings Top Views ↗

March 20, 2024

U.S. stocks traded slightly lower this morning, ahead of interest-rate decision from the Federal Reserve. Following the market opening Wednesday, the Dow traded down 0.01% to 39,106.88 while the NASDAQ...

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 20, 2024

Via Benzinga

Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes

March 20, 2024

From Lifecore Biomedical, Inc.

Via GlobeNewswire

Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023

March 20, 2024

Efforts now aligned toward the completion of its First Quarter Fiscal 2024 Report on Form 10-Q

From Lifecore Biomedical, Inc.

Via GlobeNewswire

Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal

February 16, 2024

Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company’s Securities

From Lifecore Biomedical, Inc.

Via GlobeNewswire

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report

January 12, 2024

From Lifecore Biomedical, Inc.

Via GlobeNewswire

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

January 05, 2024

From Lifecore Biomedical, Inc.

Via GlobeNewswire

Top 5 Risk Off Stocks That May Explode This Quarter ↗

December 13, 2023

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Lifecore Biomedical Provides Business Update

December 13, 2023

From Lifecore Biomedical, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.